Oct 20, 2026 08:00AM

Oct 16, 2026 04:15PM

Oct 8, 2026 08:01AM

Oct 8, 2026 08:00AM

Sep 15, 2026 07:21AM

Sep 15, 2026 03:49AM

Sep 14, 2026 12:20PM TD Cowen Reiterates Buy Rating on Scholar Rock (SRRK)

Sep 14, 2026 05:35AM

Sep 11, 2026 06:25PM

Sep 11, 2026 06:25PM

Sep 2, 2026 08:02AM

Aug 24, 2026 09:28AM

Aug 21, 2026 09:06AM

Aug 21, 2026 09:06AM Scholar Rock Provides Update on Global Apitegromab Regulatory Progress Across U.S., Europe, and Japan

Aug 10, 2026 06:41AM

Aug 7, 2026 04:20PM

Aug 6, 2026 07:00AM

Jul 20, 2026 08:00AM

Jul 20, 2026 08:00AM

Jun 22, 2026 08:00AM

Jun 18, 2026 06:57AM Scholar Rock (SRRK) Reiterated at Overweight by Cantor Fitzgerald

May 7, 2026 07:00AM

Apr 1, 2026 12:49PM

Mar 31, 2026 12:22PM

Mar 31, 2026 07:01AM

Mar 31, 2026 07:00AM

Mar 19, 2026 02:11PM

Mar 4, 2026 07:55AM 'We are incrementally positive on Scholar Rock (SRRK) Shares'; PT Raised at Piper Sandler

Mar 3, 2026 04:01PM

Mar 3, 2026 01:54PM

Mar 3, 2026 01:34PM

Mar 3, 2026 07:00AM

Mar 3, 2026 07:00AM

Jan 26, 2026 06:47AM

Jan 12, 2026 07:05AM Scholar Rock targets 2026 apitegromab BLA resubmission and launch

Jan 12, 2026 07:00AM

Nov 17, 2025 04:15PM

Nov 14, 2025 07:00AM

Oct 14, 2025 07:29AM

Oct 13, 2025 11:16AM

Sep 24, 2025 08:39AM

Sep 24, 2025 06:39AM Scholar Rock (SRRK) PT Lowered to $44 at H.C. Wainwright

Sep 24, 2025 04:15AM

Sep 23, 2025 08:20AM

Sep 23, 2025 07:00AM

Sep 23, 2025 07:00AM

Sep 17, 2025 04:36AM

Aug 21, 2025 03:06AM

Aug 14, 2025 08:00AM Pivotal SAPPHIRE Trial Data Published in The Lancet Neurology: Apitegromab Demonstrated Significant Motor Function Gains for Children and Adults with SMA on SMN-Targeted Treatment

Aug 7, 2025 07:53AM

335,212 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All